Stock Taper 
KRENSAVAGE ASSET MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Enanta Pharmaceuticals, Inc. | ENTA | 2.87M | $41.79M |
 Vanda Pharmaceuticals Inc. | VNDA | 1.18M | $7.22M |
 Embecta Corp. | EMBC | 1.14M | $3.7M |
 Ardelyx, Inc. | ARDX | 534.52K | $2.73M |
 BioMarin Pharmaceutical Inc. | BMRN | 524.79K | $30.03M |
 Ultragenyx Pharmaceutical Inc. | RARE | 390.88K | $13.05M |
 Exelixis, Inc. | EXEL | 370.69K | $20.17M |
 Sanofi | SNY | 323.95K | $13.82M |
 Supernus Pharmaceuticals, Inc. | SUPN | 280.68K | $13.05M |
 Abbott Laboratories | ABT | 200K | $18.15M |
 Jazz Pharmaceuticals plc | JAZZ | 167.82K | $40.44M |
 Evolus, Inc. | EOLS | 157.99K | $1.1M |
 InMode Ltd. | INMD | 120.94K | $1.77M |
 GSK plc | GSK | 96.73K | $5.07M |
 United Therapeutics Corporation | UTHR | 69.28K | $37.54M |
 BioNTech SE | BNTX | 59.52K | $5.54M |
 Biogen Inc. | BIIB | 20K | $4.32M |
 Regeneron Pharmaceuticals, Inc. | REGN | 6K | $3.74M |